Combination use of anti-CD133 antibody and SSA lectin can effectively enrich cells with high tumorigenicity
-
- MORIWAKI Kenta
- Department of Molecular Biochemistry and Clinical Investigation, Osaka University Graduate School of Medicine
-
- OKUDO Kumiko
- Department of Molecular Biochemistry and Clinical Investigation, Osaka University Graduate School of Medicine
-
- HARAGUCHI Naotsugu
- Department of Gastroenterological Surgery, Osaka University Graduate School of Medicine
-
- TAKEISHI Shunsaku
- GP Biosciences Ltd
-
- SAWAKI Hiromichi
- Research Center for Medical Glycoscience, National Institute of Advanced Industrial Science and Technology
-
- NARIMATSU Hisashi
- Research Center for Medical Glycoscience, National Institute of Advanced Industrial Science and Technology
-
- TANEMURA Masahiro
- Department of Gastroenterological Surgery, Osaka University Graduate School of Medicine
-
- ISHII Hideshi
- Department of Gastroenterological Surgery, Osaka University Graduate School of Medicine
-
- MORI Masaki
- Department of Gastroenterological Surgery, Osaka University Graduate School of Medicine
-
- MIYOSHI Eiji
- Department of Molecular Biochemistry and Clinical Investigation, Osaka University Graduate School of Medicine
Search this article
Journal
-
- Cancer science
-
Cancer science 102 (6), 1164-1170, 2011-06-10
- Tweet
Details 詳細情報について
-
- CRID
- 1573950399762447104
-
- NII Article ID
- 10029294388
-
- NII Book ID
- AA11808050
-
- ISSN
- 13479032
-
- Text Lang
- en
-
- Data Source
-
- CiNii Articles